【妇产科】美国妇产科医师学会2016年《早产诊治标准(临时更新)》摘译.pdf

¡¤626¡¤ ¡¾30] [31] ¡¾32¡¿ [33] ÖлªãDzúҽѧÔÓÖ¾2016Äê8ÔµÚ19¾íµÚ8ÆÚChin JPerinatMed£¬Aug£®2016£¬Vol 19£¬No 8 placental villous fragments through ATl receptoractivation[J]£® Am JPhysiol Endocrinol Metab£¬2006£¬29 1(5)£ºE 1009 1016£® DOI£º10£®I 152£¯ajpendo£®00134 2006£® Laughon SK£¬Catov J£¬Powers RW£¬eta1£®Firsttrimesteruric acidandadversepregnancy outcomes[J]£®Am JHypertens£¬20 lI£¬ 24(4)£º489¡ª495DOI£º10£®1038£¯ajh2010£®262£® Corominas Al£¬Balconi SM£¬Palermo M£¬eta1£®¡¾Serum uricacid levelsandriskofdeveloping preeclampsja¡¿[J]£®Medicina(B Aires)£®20I4£®74(6)£º462¡ª47 1 Chen Q£¬LauS£¬Tong M£¬eta1£®Serum uricacid may notbe inVOlved inthedevelopment ofpreeclampsia[J]£®J Hum Hypertens£¬20t6£¬30(2)£º136140£®DOI£º10£®1038£¯jhh£®2015£®47 Hawkins TL£¬Roberts JM£¬Mangos GJ£¬eta1£®Plasma uricacid [34¡¿ [35] remains amarker of poor outcome in hypertensive pregnancy£º aretrospective cohortstudy[J]£®BJOG£¬20 I2£¬11 9(4)£º484¡ª492£® DOI£º10£®111l£¯j£®1471¡ª0528£®2011£®03232 X£® Livingston JR£¬Payne B£¬Brown M£¬eta1£®Uric Acid as a predictor ofadversematernal andperinataloutcomes inwomen hospitalized withpreeclampsia[J]£®JObstetGynaecol Can£¬20l4£¬ 36(10)£º870¡ª877£® Zhou J£¬ZhaoX£¬WangZ£¬eta1£®Combination oflipidsanduric acidinmidsecond trimester can beused to predict adverse pregnancy outcomes[J]£®J Matern FetalNeonatal Med£¬2012£¬ 25r12)£º26332638£®DOI£º10£®3 109£¯14767058£®2012£®704447 (ÊÕ¸å¿ÚÆÚ£º20l 601¡ª06) (±¾Îı༭£ºÀ) ÃÀ¹ú¸¾²ú¿Æҽʦѧ»á2016Ä꡶Ôç²úÕï 2016Äê1Ô£¬ÃÀ¹ú¸¾²ú¿Æҽʦѧ»á(American College ofObstetricians andGynecologists£¬ACOG)ÔÚObstetrics £¦GynecologyÔÓÖ¾·¢²¼ÁË¡¶Ôç²úÕïÖαê×¼(ÁÙʱ¸üÐÂ)¡·¡­£º ¸Ã±ê×¼Óë2012Äê·¢±íµÄ±ê×¼¡±1Ïà±Èδ×÷´óµÄÐÞ¶©£¬µ«ÓëÓë ÎÒ¹úÖƶ¨µÄ¡¶Ôç²úÁÙ´²Õï¶ÏÓëÖÎÁÆÖ¸ÄÏ(2014)¡·[31Ïà±È£® ÈÔ´æÔÚһЩ²îÒ죬ÏÖ½«²¿·ÖÄÚÈÝÕûÀíÈçÏÂ= Ò»¡¢Ôç²úµÄÕï¶Ï ÔÚACOGµÄÕïÖαê×¼ÖУ¬½«Ôç²ú¶¨ÒåΪ20ÔÐÖÜ¡°¡¯ÖÁ 36ÔÐÖÜ6Ö®ÎʵķÖÃ䣬¶øÎÒ¹ú½«Ôç²ú¶¨ÒåΪ28ÔÐÖÜ¡°¡¯ÖÁ 36ÔÐÖÜ¡£Ö®¼äµÄ·ÖÃä»òÐÂÉú¶ùmÉúÌåÖØ¡Ý1 000g£¬ÕâÓë²» ͬ¹ú¼ÒÐÂÉú¶ùÕïÁÆˮƽÏà¹Ø¡£Ôç²úµÄÕï¶ÏÐèÒÀÀµÓÚlÁÙ´²Õï¶Ï ±ê×¼£¬¼´¹æÂɹ¬Ëõ£